Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol

被引:0
|
作者
Xavier León
Cristina Valero
Carlota Rovira
Camilo Rodriguez
Montserrat López
Jacinto García-Lorenzo
Miquel Quer
机构
[1] Universitat Autònoma de Barcelona,Otorhinolaryngology Department, Hospital de la Santa Creu i Sant Pau
[2] Biomateriales y Nanomedicina (CIBER-BBN),Centro de Investigación Biomédica en Red de Bioingeniería
关键词
Induction chemotherapy; Advanced laryngeal carcinoma; Organ preservation protocol; Radiotherapy; Total laryngectomy;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study is to analyze the relationship between the degree of response to induction chemotherapy and the disease control in patients with locally advanced laryngeal carcinomas candidates to total laryngectomy. This retrospective study includes 389 patients with T3–T4 laryngeal tumors candidates to total laryngectomy, diagnosed between 1985 and 2013, treated with induction chemotherapy in an organ preservation protocol. Five-year local recurrence-free survival for patients receiving conservative treatment with radiotherapy after a complete response to induction chemotherapy was 75.4%; for patients with partial response greater than 50%, it was 62.0%; and for patients with the absence of response, it was 32.7%. There were significant differences in local recurrence-free survival and laryngeal dysfunction-free survival according to the response to induction chemotherapy (P = 0.0001) at the expense of patients with absence of response to induction chemotherapy. Patients with partial response greater than 50% treated with radiotherapy had a tendency to have worse local recurrence-free survival and laryngeal dysfunction-free survival than patients with complete response, but the differences did not reach statistical significance. Patients with the absence of response after induction chemotherapy had significant differences in disease-specific survival according to the second treatment: for patients treated with surgery it was 70.2%, whereas for patients treated with radiotherapy, it was 28.2% (P = 0.0001). In patients with the absence of response to induction chemotherapy, conservative treatment with radiotherapy implies a significant decrease in survival.
引用
收藏
页码:2581 / 2587
页数:6
相关论文
共 50 条
  • [31] Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Locally Advanced Laryngeal/ Hypopharyngeal Carcinoma: Preliminary Results of INSIGHT Study
    Ou, X.
    He, X.
    Wang, Y.
    Hui, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S99 - S99
  • [32] Tumor heparanase expression in predicting response to induction chemotherapy in patients with locally advanced laryngeal cancer
    Dincer, M.
    Altundag, K.
    Cengiz, M.
    Ozyar, E.
    Sungur, A.
    Hosal, S.
    Gullu, I. H.
    JOURNAL OF BUON, 2012, 17 (02): : 337 - 342
  • [33] Efficacy and Safety of Combined Radiotherapy with EGFR Inhibitors and Chemotherapy for Laryngeal Organ Preservation in Patients with Locally Advanced Hypopharyngeal Carcinomas
    Zhang, Xinxin
    Wang, Jailing
    Wu, Wenming
    Liu, Mingbo
    Zhao, Feifang
    Du, Lei
    Huang, Deliang
    Yang, Shiming
    Ma, Lin
    CURRENT CANCER DRUG TARGETS, 2014, 14 (06) : 589 - 598
  • [34] Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
    Ou, Xiaomin
    Zhai, Ruiping
    Wei, Wenjun
    Chen, Jiaying
    Ou, Dan
    Liao, Tian
    Xu, Tingting
    Zhu, Yongxue
    Wang, Yulong
    Huang, Shenglin
    Shi, Rongliang
    Wu, Bin
    Chen, Tongzhen
    Li, Yuan
    Yang, Zhongyi
    Zhou, Changming
    Liu, Yuan
    Jiang, Ziting
    Zeng, Min
    Liu, Xin
    Ji, Dongmei
    Ying, Hongmei
    Zhang, Zhen
    Hu, Chaosu
    Lu, Xueguan
    Ji, Qinghai
    He, Xiayun
    Wang, Yu
    CLINICAL CANCER RESEARCH, 2024, 30 (02) : 344 - 355
  • [35] Induction chemotherapy and toripalimab for larynx preservation in resectable locally advanced laryngeal/hypopharyngeal carcinoma: Preliminary results of INSIGHT study.
    Ou, Xiaomin
    He, Xiayun
    Wang, Yu
    Lu, Xueguan
    Ying, Hongmei
    Ji, Dongmei
    Ji, Qinghai
    Hu, Chaosu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma
    Li, Ruichen
    Ye, Lulu
    Zhu, Yi
    Ding, Hao
    Wang, Shengzi
    Ying, Hongmei
    Wu, Chunping
    Zhou, Liang
    Wang, Xiaoshen
    Tian, Shu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (09): : 2018 - 2029
  • [37] One cycle of induction chemotherapy (IC) in advanced oropharyngeal cancer (SCCOP) to select patients for organ preservation (OP).
    Worden, FP
    Urba, S
    Bradford, C
    Carey, T
    Chepeha, D
    Prince, M
    Teknos, T
    Eisbruch, A
    Lee, J
    Tsien, C
    Wolf, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 503S - 503S
  • [38] Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy
    Popovtzer, Aron
    Burnstein, Hanna
    Stemmer, Salomon
    Limon, Dror
    Hili, Ohad
    Bachar, Gideon
    Sopov, Vladamir
    Feinmesser, Raphael
    Groshar, David
    Shvero, Jacob
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (02): : 227 - 233
  • [39] Laryngeal preservation for advanced Larynx- and Hypopharynx carcinoma through Paclitaxel/Cisplatin Induction chemotherapy and 3D Radiotherapy - clinical experience on 156 patients
    Pfreundner, L.
    Relic, A.
    Guckenberger, M.
    Polat, B.
    Voelter, C.
    Schwab, F.
    Hoppe, F.
    Hagen, R.
    Flentje, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 18 - 18
  • [40] A Study of Peripheral Blood Parameters to Predict Response to Induction Chemotherapy and Overall Survival in Advanced Laryngeal Squamous Cell Carcinoma
    Xu, Jiaqi
    Yang, Yifan
    Zhong, Qi
    Hou, Lizhen
    Ma, Hongzhi
    Zhang, Yang
    Feng, Ling
    He, Shizhi
    Lian, Meng
    Fang, Jugao
    Wang, Ru
    CURRENT ONCOLOGY, 2022, 29 (09) : 6472 - 6484